As vimentin indicated enhanced invasion and cells of invasive gliomas show a decreased proliferation rate and a relative resistance to apoptosis [18], high vimentin expression could be taken as a prognostic factor for treatment difficulty or poor survival in diffusive glioma or high-grade glioma patients. The gene discussed is VIM; the disease is central nervous system cancer.